Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 4 | |
Outperform | 7 | |
Hold | 3 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 12 analysts offering 12 month price targets for Bicycle Therapeutics PLC (ADR) have a median target of 36.50, with a high estimate of 55.00 and a low estimate of 25.00. The median estimate represents a 80.16% increase from the last price of 20.26.
High | 171.5% | 55.00 |
Med | 80.2% | 36.50 |
Low | 23.4% | 25.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 18, 2025.
Average growth rate | +8.55% |
Average growth rate | -18.10% |
More ▼
Revenue history & estimates in USD
Average growth rate | +35.62% |
Average growth rate | +24.51% |
More ▼